New research published by EFPIA provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across Member States and compares Europe to other regions of the world.

The research shows that EU pharmaceutical R&D spending grew on average 4.4% per year between 2010 and 2022, from €27.8 billion to €46.2 billion.

However, the data also provides further warning of the divergence in R&D spending between the EU and the other parts of the world, as Europe fails to keep pace with the growth seen in the sector in Asia and the US.